Cover Image
市場調查報告書

重度乾癬:全球臨床實驗檢討

Severe Psoriasis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318808
出版日期 內容資訊 英文 116 Pages
訂單完成後即時交付
價格
Back to Top
重度乾癬:全球臨床實驗檢討 Severe Psoriasis Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 116 Pages
簡介

本報告提供重度乾癬的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 重度乾癬
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要5個國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上重度乾癬所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上重度乾癬所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

重度乾癬治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AbbVie Inc.
    • Johnson & Johnson
    • Amgen Inc.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Novartis AG
    • E. Merck KG
    • F. Hoffmann-La Roche Ltd.
    • Innovaderm Research Inc.
    • Celgene Corporation
  • 有代表性的研究機關·醫院臨床實驗概要
    • Rutgers, The State University of New Jersey
    • Academic Medical Center
    • National Cancer Institute
    • University of California, San Francisco
    • Tufts Medical Center
    • Dresden University of Technology
    • University Hospitals of Leicester NHS Trust
    • Erasmus MC
    • Radboud University Nijmegen Medical Centre
    • Rockefeller University

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2408CTIDB

GlobalData's clinical trial report, "Severe Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Severe Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Severe Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Severe Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Severe Psoriasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Severe Psoriasis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Severe Psoriasis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Severe Psoriasis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Severe Psoriasis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Innovaderm Research Inc.
      • Clinical Trial Overview of Innovaderm Research Inc.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • Rutgers, The State University of New Jersey
      • Clinical Trial Overview of Rutgers, The State University of New Jersey
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Tufts Medical Center
      • Clinical Trial Overview of Tufts Medical Center
      • Dresden University of Technology
      • Clinical Trial Overview of Dresden University of Technology
      • University Hospitals of Leicester NHS Trust
      • Clinical Trial Overview of University Hospitals of Leicester NHS Trust
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Radboud University Nijmegen Medical Centre
      • Clinical Trial Overview of Radboud University Nijmegen Medical Centre
      • Rockefeller University
      • Clinical Trial Overview of Rockefeller University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Severe Psoriasis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Severe Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Severe Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Severe Psoriasis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Severe Psoriasis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Severe Psoriasis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Severe Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts Medical Center, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rockefeller University, 2014*

List of Figures

  • Severe Psoriasis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Severe Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Severe Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Severe Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Severe Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Severe Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top